Explore more Norwegian companies →

COMPANY CARD COMPANY

SERCA PHARMACEUTICALS AS

Business reg. no. 921 663 846ASOSLOIndustry code 72.100

Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk

Equity ratio: Good · 69,3 % (2025)
Company financial statements in NOK · 2023: 3 571 688 NOK · 2024: 4 714 624 NOK · 2025: 2 962 524 NOK
2023–2025 · NOK
Operating revenue3,0 mill. NOK
2025 · company↓ 37,2 % from 2024
Company financial statements in NOK · 2023: -4 421 243 NOK · 2024: -1 526 506 NOK · 2025: 10 752 NOK
2023–2025 · NOK
Operating income · EBIT10 752 NOK
2025 · company↑ 1,5 mill. NOK from 2024

0,4 % EBIT-margin

Registered employees0 employees
RegistrertRegistry data 06.11.2026

FINANCIALS

Financial statements and key figures

Amount in whole currency units
Company financial statements

Amount in NOK

Company financial statements · amounts without rounding to thousands for display
Financial statement item202520242023
CurrencyNOKNOKNOK
Operating revenue2 962 5244 714 6243 571 688
Operating profit10 752-1 526 506-4 421 243
Net income131 820-1 159 259-4 423 990
Equity27 895 94027 645 23816 391 412
Total assets40 227 57140 622 02617 923 659
EBIT margin0,4 %-32,4 %-123,8 %

Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.

Show trend in NOK
Operating revenueNOK · 2023–20253,0 mill. NOK
↓ 37,2 % from 2024
Operating revenue202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Operating profitNOK · 2023–202510 752 NOK
↑ 1,5 mill. NOK from 2024
Operating profit202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Sources and conversion basis

Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.

  • 2025 · NOK · original-NOK · source version 8fd2beccc3d1
  • 2024 · NOK · original-NOK · source version 9ae1d3fc5e26
  • 2023 · NOK · original-NOK · source version 5496fc1062bf

Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.

Income statement3 entries with information
Company financial statements · Income statement · whole currency units
Financial statement item202520242023
Operating revenue
Total operating revenue2 962 5244 714 6243 571 688
Operating profit
Operating income (EBIT)10 752-1 526 506-4 421 243
Results and tax
Net income131 820-1 159 259-4 423 990
Balance sheet2 entries with information
Company financial statements · Balance sheet · whole currency units
Financial statement item202520242023
Current assets
Total assets40 227 57140 622 02617 923 659
Equity
Total equity27 895 94027 645 23816 391 412
Executive salaryUnavailable

No information in the available financial statement data.

REGISTRY INFORMATION

Company at a glance

Registrert
Industry
72.100 · Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk
Registered address
Gaustadalléen 21, 0349 OSLO
Founded
08.10.2018
Entity type
Main entity

ADDRESS AND PROPERTY

Property information

Open data

Gaustadalléen 21, 0349 OSLO

Loading property information …

© Kartverket · CC BY 4.0

Companies at the same address

Available company cards

    About the address match

    Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.

    REGISTERED ROLES

    The people and companies behind it.

    Search registered roles →Explore positions and documented connections.
    NameRoleSource date
    Kristin SandereidBorn 1968Styremedlem17.10.2026
    UNIC REVISJON ASView role recordRevisor17.10.2026
    Erlend Petter SkagsethBorn 1955Styrets leder17.10.2026
    Jonas HallénBorn 1978Styremedlem17.10.2026
    STATEMENT ASView role recordRegnskapsfører17.10.2026
    Jens Halvard GrønlienBorn 1974Styremedlem17.10.2026
    Kjetil HestdalBorn 1960Daglig leder17.10.2026

    Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.

    YEAR-DATED OWNERSHIP

    Reported shareholders.

    Search shareholders →Find a shareholder and follow reported ownership entries.

    As of 31 December 2025 · 10 av 15 available ownership entries

    Distribution of share count 31.12.2025
    84,6 %displayed share of shares
    • SARSIA SEED FOND II ASOrdinære aksjer40,45 %
    • INVEN2 ASOrdinære aksjer26,13 %
    • SATURN INVEST ASOrdinære aksjer10,90 %
    • HERSETH ASOrdinære aksjer4,47 %
    • K OG K ASOrdinære aksjer2,61 %
    • Other / undisplayed records15,44 %

    Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.

    Multiple company owners (1)
    ShareholderShare / share classSource date
    DRUG DISCOVERY LABORATORY ASView ownership entryView share entries →0,33 % · Ordinære aksjer31.12.2025

    Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.

    Previously reported ownership entries (30)

    YEAR-DATED OWNERSHIP

    Company share entries

    The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.

    YEAR-DATED OWNERSHIP

    Indirect ownership

    Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.

    CONNECTIONS

    Explore the ownership structure.

    Directly reported ownership entries are shown first. Open the map to explore further.

    Direct ownership entries without an interactive map

    As of 31 December 2025 · 10 av 15 available ownership entries

    Multiple company owners (1)
    ShareholderShare / share classSource date
    DRUG DISCOVERY LABORATORY ASView ownership entryView share entries →0,33 % · Ordinære aksjer31.12.2025

    Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.

    Open interactive map for direct ownership entries

    CONNECTIONS

    Explore the ownership structure.

    See owners and open further company levels, using the same year throughout the tree.

    Year-end ownership